Biopharmaceuticals. Official position of Russian Association of Endocrinologists
Some of the glucose-lowering drugs are biopharmaceuticals. This letter states the official position of the Russian Association of Endocrinologists about the treatment with biopharmaceuticals of patients with endocrine disorders. This topic has not yet beenadequately reflected in the legal r...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Endocrinology Research Centre
2013-09-01
|
| Series: | Сахарный диабет |
| Subjects: | |
| Online Access: | https://www.dia-endojournals.ru/jour/article/view/830 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849327319445929984 |
|---|---|
| author | Editorial team Diabetes Mellitus |
| author_facet | Editorial team Diabetes Mellitus |
| author_sort | Editorial team Diabetes Mellitus |
| collection | DOAJ |
| description | Some of the glucose-lowering drugs are biopharmaceuticals. This letter states the official position of the Russian Association of Endocrinologists about the treatment with biopharmaceuticals of patients with endocrine disorders. This topic has not yet beenadequately reflected in the legal regulation of the drug market in the Russian Federation . |
| format | Article |
| id | doaj-art-4eeaff4efdb14ba69166bfb8cfbb7594 |
| institution | Kabale University |
| issn | 2072-0351 2072-0378 |
| language | English |
| publishDate | 2013-09-01 |
| publisher | Endocrinology Research Centre |
| record_format | Article |
| series | Сахарный диабет |
| spelling | doaj-art-4eeaff4efdb14ba69166bfb8cfbb75942025-08-20T03:47:54ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782013-09-0116312112210.14341/2072-0351-830810Biopharmaceuticals. Official position of Russian Association of EndocrinologistsEditorial team Diabetes Mellitus0Russian Association of Endocrinologists, MoscowSome of the glucose-lowering drugs are biopharmaceuticals. This letter states the official position of the Russian Association of Endocrinologists about the treatment with biopharmaceuticals of patients with endocrine disorders. This topic has not yet beenadequately reflected in the legal regulation of the drug market in the Russian Federation .https://www.dia-endojournals.ru/jour/article/view/830russian association of endocrinologistsbiopharmaceuticalsinsulinbioequivalence |
| spellingShingle | Editorial team Diabetes Mellitus Biopharmaceuticals. Official position of Russian Association of Endocrinologists Сахарный диабет russian association of endocrinologists biopharmaceuticals insulin bioequivalence |
| title | Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_full | Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_fullStr | Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_full_unstemmed | Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_short | Biopharmaceuticals. Official position of Russian Association of Endocrinologists |
| title_sort | biopharmaceuticals official position of russian association of endocrinologists |
| topic | russian association of endocrinologists biopharmaceuticals insulin bioequivalence |
| url | https://www.dia-endojournals.ru/jour/article/view/830 |
| work_keys_str_mv | AT editorialteamdiabetesmellitus biopharmaceuticalsofficialpositionofrussianassociationofendocrinologists |